… (NASDAQ:RPID) Q3 2025 Earnings Call Transcript November 7, … Micro Biosystems, Inc. beats earnings expectations. Reported EPS is … Biosystems Third Quarter 2025 Earnings Conference Call. [Operator … 2026. Next week, Daiichi Sankyo will support our annual …

… (NASDAQ:ESPR) Q3 2025 Earnings Call Transcript November 6, 2025 … Therapeutics, Inc. misses on earnings expectations. Reported EPS is … s Third Quarter 2025 Earnings Conference Call. With us … Europe, where our partner, Daiichi Sankyo Europe continues to deliver …

… to include Datroway (datopotamab deruxtecan). Daiichi Sankyo is responsible for the manufacturing … , estimates for ANI Pharmaceuticals’ 2025 earnings per share (EPS) have increased … the past year. ANI Pharmaceuticals’ earnings beat estimates in each of …

… leading multinational pharmaceutical companies, including Daiichi Sankyo Korea, Sanofi Korea, and MSD … and Growth" category of Daiichi Sankyo’s Core Behavior Award, recognizing … from launch to patent expiry, earning her recognition as a seasoned …

Daiichi Sankyo Company, Limited (OTCPK:DSKYF) FY2024 Earnings Conference Call April 25, 2025 … we would like to begin Daiichi Sankyo's Financial Results Conference … schedule today to attend the Daiichi Sankyo’s financial results briefing. I …

… amp; Co., Inc. beats earnings expectations. Reported EPS is $2 … J., USA Q2 Sales and Earnings Conference Call. [Operator Instructions] … slides, along with the earnings release, today’s prepared … , through our collaboration with Daiichi Sankyo, we now have 3 …

… Enhertu, AstraZeneca and Daiichi Sankyo’s blockbuster HER2 cancer … raising the possibility that Daiichi Sankyo will have competing products … oncology clinical development at Daiichi Sankyo, discussed how that … AstraZeneca, said on an earnings call in November. …

… per cent after Japanese drugmaker Daiichi Sankyo fil­ed a contempt plea against … said in the company’s earnings call for Q2 FY26. However …

… (NYSE:ZYME) Q1 2025 Earnings Call Transcript May 8, 2025 … Zymeworks Inc. beats earnings expectations. Reported EPS is $- … million of milestone revenue from Daiichi Sankyo following the first patient … you to review our earnings release and other SEC …

… (NASDAQ:ESPR) Q1 2025 Earnings Call Transcript May 6, 2025 … Therapeutics, Inc. misses on earnings expectations. Reported EPS is … ’s First Quarter 2025 Earnings Conference Call. With us … compelling growth from our partner Daiichi Sankyo Europe, where they are …